Search

Your search keyword '"Pam R. Taub"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Pam R. Taub" Remove constraint Author: "Pam R. Taub"
134 results on '"Pam R. Taub"'

Search Results

1. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center

2. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management

Catalog

Books, media, physical & digital resources

3. Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran

4. Mitochondrial impairment but not peripheral inflammation predicts greater Gulf War illness severity

5. LIPID TRENDS ON DONOR DERIVED ATHEROSCLEROTIC DISEASE AND ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS AT A LARGE ACADEMIC CENTER

6. ONE YEAR EXPERIENCE WITH INCLISIRAN IN AN ACADEMIC LIPID CLINIC

7. High density lipoprotein: When to rethink too much of a good thing

8. Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery disease

9. Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis

10. Ten things to know about ten cardiovascular disease risk factors

11. Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection

12. Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology

13. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation

14. Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic

16. Improvement of hyperadrenergic postural orthostatic tachycardia syndrome (POTS) with methylated B vitamins in the setting of a heterozygous COMT Val158Met polymorphism

17. Postural orthostatic tachycardia syndrome as a sequela of COVID-19

18. 2 Cases of Elusive Left Ventricular Outflow Tract Gradient

20. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play

21. Heart-Healthy Diets and the Cardiometabolic Jackpot

22. Efficacy and Safety of Bempedoic Acid in Patients With and Without Metabolic Syndrome: Pooled Analysis of Data From Four Phase 3 Clinical Trials

23. Diabetes With Cardiomyopathy

24. Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failure

25. Cardiac rehabilitation for coronary artery disease: latest updates

26. Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure

27. Time for better time-restricted eating trials to lessen the burden of metabolic diseases

28. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model

29. Current challenges in cardiac rehabilitation: strategies to overcome social factors and attendance barriers

30. Effect of closed loop stimulation versus accelerometer on outcomes with cardiac resynchronization therapy: the CLASS trial

31. Intermittent Fasting: A Heart Healthy Dietary Pattern?

32. May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: a case series

33. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

35. Deep Learning Automated Background Phase Error Correction for Abdominopelvic 4D Flow MRI

36. Abstract 9797: Efficacy and Safety of Bempedoic Acid in Patients with Metabolic Syndrome

37. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice

38. Time-restricted Eating for the Prevention and Management of Metabolic Diseases

39. Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship

40. Feasibility of time-restricted eating and impacts on cardiometabolic health in 24-h shift workers: The Healthy Heroes randomized control trial

42. 971-P: Prevalence of Diabetic Cardiomyopathy in Real-World Practice: A Longitudinal Cohort Study

43. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation

44. Baseline testosterone level may modulate statin efficacy

45. Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities

46. Ten things to know about ten cardiovascular disease risk factors

47. Impact of Nutrition on Biomarkers of Cardiovascular Health

48. Pilot Clinical Trial of Time-Restricted Eating in Patients with Metabolic Syndrome

49. Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection

50. Secondary Prevention and Cardiac Rehabilitation